Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_assertion type Assertion NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_head.
- NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_assertion description "[The EGR1 transactivator is overexpressed in prostate cancer, and its expression pattern suggests that EGR1 could potentially regulate a number of steps involved in initiation and progression of prostate cancer, such as mitogenesis, invasiveness, angiogenesis, and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance.
- NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_assertion evidence source_evidence_literature NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance.
- NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_assertion SIO_000772 10984481 NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance.
- NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_assertion wasDerivedFrom befree-20150227 NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance.
- NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_assertion wasGeneratedBy ECO_0000203 NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance.